|
Bravo-Perez C, Sola M, Teruel-Montoya R, Garcia-Malo MD, Ortuno FJ, Vicente V, de Arriba F, Jerez A. Minimal Residual Disease in Multiple Myeloma: Something Old, Something New. Cancers (Basel). 2021 Aug 27;13(17):4332. doi: 10.3390/cancers13174332. PubMed PMID: 34503142; PubMed Central PMCID: PMC8430644.
AÑO: 2021; IF: 6.575
|
34503142
|
Bravo-Perez C, Fernandez-Caballero M, Soler-Espejo E, Garcia-Torralba E, Sorigue M, Garcia-Malo MD, Jerez A, Vicente V, Roldan V, de Arriba F. Heparin versus aspirin thromboprophylaxis adds independent value to IMPEDE-VTE score for venous thrombosis prediction in multiple myeloma. J Thromb Thrombolysis. 2021 Oct;52(3):848-853. doi: 10.1007/s11239-021-02407-5. Epub 2021 Mar 1. PubMed PMID: 33649980.
AÑO: 2021; IF: 5.221
|
|
Carrillo-Tornel S, Chen-Liang TH, Zurdo M, Puiggros A, Gomez-Llonin A, Garcia-Malo MD, Cuenca-Zamora EJ, Ortuno FJ, Lopez AMH, Espinet B, Jerez A. NOTCH1 mutation in chronic lymphocytic leukaemia is associated with an enhanced cell cycle G1/S transition and specific cyclin overexpression: Preclinical ground for targeted inhibition. Br J Haematol. 2023 May;201(3):470-479. doi: 10.1111/bjh.18609. Epub 2022 Dec 27. PubMed PMID: 36573331.
AÑO: 2023; IF: 5.1
|